Detection of SARS-CoV-2 Based on Nucleic Acid Amplification Tests

• Published in: International journal of molecular sciences Vol. 24; no. 12
• Main Authors: Dorta-Gorrín, Alexis, Navas-Méndez, Jesús, Gozalo-Margüello, Mónica, Miralles, Laura, García-Hevia, Lorena
• Format: Journal Article
• Language: English
• Published: MDPI AG 01.06.2023
• Subjects: Coronaviruses; Genomics; Health aspects; Nucleic acids; Spain
• ISSN: 1422-0067
• DOI: 10.3390/ijms241210233

The coronavirus SARS-CoV-2 has highlighted the criticality of an accurate and rapid diagnosis in order to contain the spread of the virus. Knowledge of the viral structure and its genome is essential for diagnosis development. The virus is still quickly evolving and the global scenario could easily change. Thus, a greater range of diagnostic options is essential to face this threat to public health. In response to the global demand, there has been a rapid advancement in the understanding of current diagnostic methods. In fact, innovative approaches have emerged, leveraging the benefits of nanomedicine and microfluidic technologies. Although this development has been incredibly fast, several key areas require further investigation and optimization, such as sample collection and preparation, assay optimization and sensitivity, cost effectiveness, scalability device miniaturization, and portability and integration with smartphones. Addressing these gaps in the knowledge and these technological challenges will contribute to the development of reliable, sensitive, and user-friendly NAAT-based POCTs for the diagnosis of SARS-CoV-2 and other infectious diseases, facilitating rapid and effective patient management. This review aims to provide an overview of current SARS-CoV-2 detection methods based on nucleic acid detection tests (NAATs). Additionally, it explores promising approaches that combine nanomedicine and microfluidic devices with high sensitivity and relatively fast ‘time to answer’ for integration into point-of-care testing (POCT).